PROFESSIONAL SERVICES
BIOPHARMA BUSINESS DEVELOPMENT
Prescient Crossborder’s biomedical business development focuses on the entire biopharma product life cycle. Taking the company from product concept through production and market.
PRESCIENT BIOPHARMA BUSINESS DEVELOPMENT
Prescient Crossborder is a reliable source for capital, key expertise, technology & product. Focusing on serving emerging and growth companies, our biopharma business development covers the entire biopharma product life cycle. Taking the company from product concept through production and market.
What we do:
- Strategically position the client technology or program for alliance/ partnership;
- Identify and develop a targeted list of prospective partners from the international biopharma industry;
- Proactively engage and facilitate meetings and dialogue with prospective partners;
- Prepare financial/business models to support the negotiation of optimal terms;
- Negotiate commercial partnerships, including negotiation of term sheets and licensing agreements;
- Assist in licensing, acquisitions and divestitures;
- Represent non-US companies within North America;
- Identify competitors/collaborators and barriers to entry;
- Facilitate global operation, marketing, manufacturing and distribution;
- Management, board and key technical/business expertise recruitment;
- Funding and stock offering;
- Preparation of business and marketing plans;
- Seed investment, angel and venture financing;
- Private placement and IPO offering.
Solving Business Development Problems
Our Associates have successfully grown businesses in the healthcare industry, providing us a skilled perspective at guiding the strategic decisions.
We help you to answer:
1.What is the value of a business opportunity? Strategically? Financially?
2.What is the most viable commercialization strategy?
3.Who are good potential partners?
4. How do we set up international distribution
5. What are the key product development and commercialization issues
6. What should our strategy be for contract negotiations?
Biomedical business development service, including but not limited to:
- Fulfilling the needs of international biotechnology/pharmaceutical and investment companies seeking new products, new technologies, partnership, investment and/or new business opportunities;
- Assisting in screening and recruiting potential international business partners and investors in China, Europe and North America;
- Deal Negotiation: Assisting clients with development of terms for their joint venture, partnership, alliance and/or collaboration;
- Product/Technology sourcing:
- Assisting clients with sourcing biomedical products and related services in China and other international countries;
- Product and technology development and commercialization;
- Project planning and execution plans;
- New venture development: Assisting its potential clients to plan and launch new ventures with primary focus on biotechnology startup;
- Marketing and distribution of biopharmaceutical products in China and across the world;
- Screening and Recruiting qualified key experts, advisors and OEM companies;
- Chinese Market Research: In close relationship with local Chinese organizations to assess business opportunities and strategies.
PRESCIENT CROSSBORDER
MORE SERVICES
Equity Financing Service
Prescient Crossborder connects enterprises with suitable strategic investors, and also ensures the enterprises can obtain resources other than funds that enabling them to fully expand their business.
IPO Advisory Service
Prescient Crossborder is committed to guiding companies to list overseas, protecting the company on the road of going public. With years of experience and strong resources, we are confident that we can meet the diversified listing needs of different companies.
Restructuring and M&A Service
Prescient Crossborder seeks suitable M&A targets for the buyer, brings the buyer and seller together, aims on reaching a win-win situation for both parties, and assists the enterprise to implement the strategic and integration plan after the merger and acquisition.
